within Pharmacolibrary.Drugs.C_CardiovascularSystem.C09C_AngiotensinIiReceptorBlockersArbsPlain.C09CA04_Irbesartan;

model Irbesartan
  extends Pharmacolibrary.Drugs.ATC.C.C09CA04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C09CA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Irbesartan is an angiotensin II receptor blocker (ARB) used for the treatment of hypertension and diabetic nephropathy in type 2 diabetes. It is approved and currently used in clinical practice as an oral antihypertensive agent, typically as monotherapy or in combination with other antihypertensive drugs.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single oral dose.</p><h4>References</h4><ol><li><p>Alhazmi, HA, et al., &amp; Taha, MME (2022). Study of influence of . <i>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</i> 30(3) 237–244. DOI:<a href=&quot;https://doi.org/10.1016/j.jsps.2022.01.002&quot;>10.1016/j.jsps.2022.01.002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35498225/&quot;>https://pubmed.ncbi.nlm.nih.gov/35498225</a></p></li><li><p>Marino, MR, &amp; Vachharajani, NN (2002). Pharmacokinetics of irbesartan are not altered in special populations. <i>Journal of cardiovascular pharmacology</i> 40(1) 112–122. DOI:<a href=&quot;https://doi.org/10.1097/00005344-200207000-00014&quot;>10.1097/00005344-200207000-00014</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12072584/&quot;>https://pubmed.ncbi.nlm.nih.gov/12072584</a></p></li><li><p>Vaidyanathan, S, et al., &amp; Dole, WP (2007). Pharmacokinetics of the oral direct renin inhibitor aliskiren alone and in combination with irbesartan in renal impairment. <i>Clinical pharmacokinetics</i> 46(8) 661–675. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200746080-00003&quot;>10.2165/00003088-200746080-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17655373/&quot;>https://pubmed.ncbi.nlm.nih.gov/17655373</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Irbesartan;
